APA (7th ed.) Citation

Streubel, G., Schrepfer, S., Kallus, H., Parnitzke, U., Wulff, T., Hermann, F., . . . Hamm, S. (2021). Histone deacetylase inhibitor resminostat in combination with sorafenib counteracts platelet-mediated pro-tumoral effects in hepatocellular carcinoma. Nature Portfolio.

Chicago Style (17th ed.) Citation

Streubel, Gundula, Sabine Schrepfer, Hannah Kallus, Ulrike Parnitzke, Tanja Wulff, Frank Hermann, Matthias Borgmann, and Svetlana Hamm. Histone Deacetylase Inhibitor Resminostat in Combination with Sorafenib Counteracts Platelet-mediated Pro-tumoral Effects in Hepatocellular Carcinoma. Nature Portfolio, 2021.

MLA (8th ed.) Citation

Streubel, Gundula, et al. Histone Deacetylase Inhibitor Resminostat in Combination with Sorafenib Counteracts Platelet-mediated Pro-tumoral Effects in Hepatocellular Carcinoma. Nature Portfolio, 2021.